Archive for the ‘plos one’ Category
Two journals have retracted two papers by the same group within months of each other, after editors were independently tipped off that they contained duplicated figures representing different experiments.
The two papers were published by PLOS ONE and The Egyptian Journal of Biochemistry and Molecular Biology (EJBMB) in 2015 and 2014, respectively. According to the PLOS ONE paper’s corresponding author, last author Saad A. Noeman from Tanta University in Egypt used the same Figure 1 in both papers, along with another 2013 paper in EJBMB.
Corresponding author Yasser S. El-Sayed, head of the Department of Forensic Medicine and Toxicology at Damanhour University in Egypt, told us he learned of this issue after a reader brought the figure manipulation and duplication concerns to PLOS ONE’s attention.
El-Sayed said that he tried to figure out what had happened.
By some measures, 2016 was a somewhat rocky year for PLOS ONE — it issued some high-profile retractions, and published fewer papers, in part due to a decline in submissions. Still, the first multidisciplinary open-access journal — which accepts all submissions that meet technical and ethical standards, regardless of the results — publishes more than 20,000 papers per year, juggling thousands of editors and reviewers. So what does the future hold for this “large and complex” journal? We spoke with its new editor, Joerg Heber, who assumed the role in November.
Retraction Watch: What are your primary goals for the journal, and how do you plan to achieve them?
Following a journal probe and questions on PubPeer about their work, authors in Spain have issued four corrections, citing missing raw data for experiments conducted more than 10 years ago.
All papers include the same last two authors, Mireia Duñach at the Autonomous University of Barcelona, and Antonio García de Herreros at the Institut Hospital del Mar d’Investigacions Mèdiques.
Three of the corrections were issued by the Journal of Biological Chemistry, from which the authors retracted three papers earlier this year after a journal investigation concluded they contain reused images, designed to represent different experiments.
Duñach told us the latest corrections are the result of her own initiation:
A new analysis of retractions from Korean journals reveals some interesting trends.
For one, the authors found most papers in Korean journals are retracted for duplication (57%), a higher rate than what’s been reported in other studies. The authors also deemed some retractions were “inappropriate” according to guidelines established by the Committee on Publication Ethics (COPE) — for instance, retracting the article another paper duplicated from, or pulling a paper when an erratum would have sufficed.
One sentence from “Characteristics of Retractions from Korean Medical Journals in the KoreaMed Database: A Bibliometric Analysis,” however, particularly struck us: Read the rest of this entry »
Pharmaceutical giant Pfizer has announced it plans to retract five papers by a former employee, after an investigation found duplicated images.
As first reported today by Leonid Schneider, Pfizer has asked to retract five papers from the lab of Min-Jean Yin, a cancer researcher. A spokesperson for the company confirmed to us that Yin had been fired:
…Min-Jean Yin’s employment has been terminated as a result of our investigation.
The five papers to be retracted are: Read the rest of this entry »
Consider this: Fragments of a PLOS ONE paper overlap with pieces of other publications. The authors used them without credit and without quotation marks.
This sounds an awful lot like plagiarism — using PLOS‘s own standards, even. But the journal isn’t calling it plagiarism. They’ve labeled this an instance of “text overlap,” a spokesperson told us, based on the amount of material that the paper shares with others.
The last author — Carlo Croce, who has two retractions under his belt — denies that he plagiarized, and says that his university has cleared him of a plagiarism charge from an anonymous whistleblower.
PLOS fixed this case last year with a correction notice — not the common course of action for a case of confirmed plagiarism. Take a look at the notice for yourself:
PLOS ONE has retracted three papers after the first author admitted to submitting the manuscripts without co-authors’ consent, and an investigation suggested that two out of the three papers had received faked reviews.
Last August, the same author — Lishan Wang of the Shanghai Jiao Tong University — lost two more papers (one in Tumor Biology and the other in Gene), also after the peer review process was found to be compromised. All five papers — which share other authors in common — were originally published in 2013, and four list Wang as the first author. The retractions follow an investigation by Shanghai Jiao Tong University.
When a high-profile psychologist reviewed her newly published paper in PLOS ONE, she was dismayed to notice multiple formatting errors.
So she contacted the journal to find out what had gone wrong, especially since checking the page proofs would have spotted the problem immediately. The authors were surprised to learn that it was against the journal’s policy to provide authors page proofs. Could this partly explain PLOS ONE’s high rate of corrections?
Issuing frequent corrections isn’t necessarily a bad thing, since it can indicate that the journal is responsive to fixing published articles. But the rate of corrections at PLOS ONE is notably high. Read the rest of this entry »
According to the first author of the paper — Hafsa Athar Jafree from the University of Karachi in Pakistan — none of the authors agreed to the EOC notice. She told us the paper contains a few typos, which may have made it unclear to some readers, but said the authors had provided all of the necessary information to “justify the presented algorithms.”
A PLOS ONE spokesperson told us the journal decided to issue an EOC after consulting the editorial board, which raised significant concerns about the study.
In 2014, the journal issued a correction to the study to fix several equations in the original article.
PLOS ONE has now retracted the paper, noting that they were tipped off to the problems by a reader who raised concerns about some of the figures. The notice states that the study’s first author, Zhenni Zhang, takes full responsibility.
The last author of the paper — Zongfang Li from the Xi’an Jiaotong University in China — told us Zhang was his PhD student who was close to completing her PhD, but has now been expelled.